Suppr超能文献

有益人体肠道细菌对抗性淀粉的利用

Resistant starch utilization by , the beneficial human gut bacteria.

作者信息

Jung Dong-Hyun, Park Cheon-Seok

机构信息

Microorganism Resources Division, National Institute of Biological Resources, Incheon, 22689 Republic of Korea.

Division of Food and Nutrition, Chonnam National University, Gwangju, 61186 Republic of Korea.

出版信息

Food Sci Biotechnol. 2023 Jan 27;32(4):441-452. doi: 10.1007/s10068-023-01253-w. eCollection 2023 Mar.

Abstract

Resistant starch (RS) reaches the large intestine largely intact, where it is fermented by the gut microbiota, resulting in the production of short-chain fatty acids (SCFAs) that have beneficial effects on the human body. Bifidobacteria are a major species widely used in the probiotic field, and are increased in the gut by RS, indicating their importance in RS metabolism in the intestine. Bifidobacteria have a genetic advantage in starch metabolism as they possess a significant number of starch-degrading enzymes and extraordinary three RS-degrading enzymes, allowing them to utilize RS. However, to date, only three species of RS-degrading bifidobacteria have been reported as single isolates , and . In this review, we describe recent studies on RS utilization by , based on their biochemical characteristics and genetic findings. This review provides a crucial understanding of how bifidobacteria survive in specific niches with abundant RS such as the human gut.

摘要

抗性淀粉(RS)在很大程度上完整地到达大肠,在那里它被肠道微生物群发酵,产生对人体有益的短链脂肪酸(SCFAs)。双歧杆菌是益生菌领域广泛使用的主要菌种,并且在肠道中因RS而增加,表明它们在肠道RS代谢中的重要性。双歧杆菌在淀粉代谢方面具有遗传优势,因为它们拥有大量淀粉降解酶和三种特殊的RS降解酶,使其能够利用RS。然而,迄今为止,仅报道了三种降解RS的双歧杆菌作为单一分离株,即[具体菌株1]、[具体菌株2]和[具体菌株3]。在这篇综述中,我们基于其生化特性和遗传学研究结果,描述了关于[具体双歧杆菌属]对RS利用的最新研究。这篇综述对于理解双歧杆菌如何在富含RS的特定生态位(如人类肠道)中生存至关重要。

相似文献

1
Resistant starch utilization by , the beneficial human gut bacteria.有益人体肠道细菌对抗性淀粉的利用
Food Sci Biotechnol. 2023 Jan 27;32(4):441-452. doi: 10.1007/s10068-023-01253-w. eCollection 2023 Mar.

引用本文的文献

9
Bacterial interactions on nutrient-rich surfaces in the gut lumen.肠道腔中富含营养的表面上的细菌相互作用。
Infect Immun. 2024 Sep 10;92(9):e0048023. doi: 10.1128/iai.00480-23. Epub 2024 Mar 20.

本文引用的文献

1
Carbohydrate-active enzymes (CAZymes) in the gut microbiome.肠道微生物组中的碳水化合物活性酶(CAZymes)。
Nat Rev Microbiol. 2022 Sep;20(9):542-556. doi: 10.1038/s41579-022-00712-1. Epub 2022 Mar 28.
3
Resistant starch, microbiome, and precision modulation.抗性淀粉、微生物组和精准调控。
Gut Microbes. 2021 Jan-Dec;13(1):1926842. doi: 10.1080/19490976.2021.1926842.
6
SCFA: mechanisms and functional importance in the gut.短链脂肪酸:在肠道中的作用机制和重要功能。
Proc Nutr Soc. 2021 Feb;80(1):37-49. doi: 10.1017/S0029665120006916. Epub 2020 Apr 2.
9
Resistant starch: impact on the gut microbiome and health.抗性淀粉:对肠道微生物组和健康的影响。
Curr Opin Biotechnol. 2020 Feb;61:66-71. doi: 10.1016/j.copbio.2019.10.008. Epub 2019 Nov 22.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验